Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Waltraut Kopp

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos One|December 31, 2013
Interferon-λ4 (IFNL4) transcript expression in human liver tissue samplesAhmad Amanzada, Waltraut Kopp, Ulrich Spengler, et al.
Cancers|December 24, 2021
HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma CellsKatharina M Ewers, Shilpa Patil, Waltraut Kopp, et al.
Cells|December 24, 2021
Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic CancerShilpa Patil, Teresa Forster, Kristina Reutlinger, et al.
Cancers|July 27, 2022
<i>TP53</i>-Status-Dependent Oncogenic EZH2 Activity in Pancreatic CancerLennart Versemann, Shilpa Patil, Benjamin Steuber, et al.
Cancer Research|January 13, 2021
STIM1 Mediates Calcium-Dependent Epigenetic Reprogramming in Pancreatic CancerAna P Kutschat, Feda H Hamdan, Xin Wang, et al.
Cell Death & Disease|December 23, 2025
Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cellsMaj-Britt Paulsohn, Klara Henrike Frahnert, Denise Schlösser, et al.
Cancer Research|September 10, 2020
EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of <i>GATA6</i>Shilpa Patil, Benjamin Steuber, Waltraut Kopp, et al.
Gut|January 30, 2025
Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancerThomas L Ekstrom, Raya M Rosok, Amro M Abdelrahman, et al.
Gut|March 8, 2023
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancerFeda H Hamdan, Amro M Abdelrahman, Ana Patricia Kutschat, et al.
Gastroenterology|November 1, 2023
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational TherapiesMarie C Hasselluhn, Denise Schlösser, Lennart Versemann, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|December 31, 2013
Interferon-λ4 (IFNL4) transcript expression in human liver tissue samplesAhmad Amanzada, Waltraut Kopp, Ulrich Spengler, et al.
Cancers|December 24, 2021
HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma CellsKatharina M Ewers, Shilpa Patil, Waltraut Kopp, et al.
Cells|December 24, 2021
Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic CancerShilpa Patil, Teresa Forster, Kristina Reutlinger, et al.
Cancers|July 27, 2022
<i>TP53</i>-Status-Dependent Oncogenic EZH2 Activity in Pancreatic CancerLennart Versemann, Shilpa Patil, Benjamin Steuber, et al.
Cancer Research|January 13, 2021
STIM1 Mediates Calcium-Dependent Epigenetic Reprogramming in Pancreatic CancerAna P Kutschat, Feda H Hamdan, Xin Wang, et al.
Cell Death & Disease|December 23, 2025
Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cellsMaj-Britt Paulsohn, Klara Henrike Frahnert, Denise Schlösser, et al.
Cancer Research|September 10, 2020
EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of <i>GATA6</i>Shilpa Patil, Benjamin Steuber, Waltraut Kopp, et al.
Gut|January 30, 2025
Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancerThomas L Ekstrom, Raya M Rosok, Amro M Abdelrahman, et al.
Gut|March 8, 2023
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancerFeda H Hamdan, Amro M Abdelrahman, Ana Patricia Kutschat, et al.
Gastroenterology|November 1, 2023
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational TherapiesMarie C Hasselluhn, Denise Schlösser, Lennart Versemann, et al.
Pageof 1